ANKRD1 Blocking Peptide (N-Term)
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q15327 |
---|---|
Other Accession | Q3ZBX7, Q865U8 |
Gene ID | 27063 |
---|---|
Other Names | Ankyrin repeat domain-containing protein 1, Cardiac ankyrin repeat protein, Cytokine-inducible gene C-193 protein, Cytokine-inducible nuclear protein, ANKRD1, C193, CARP, HA1A2 |
Target/Specificity | The synthetic peptide sequence is selected from aa 22-34 of HUMAN ANKRD1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | ANKRD1 |
---|---|
Synonyms | C193, CARP, HA1A2 |
Function | May play an important role in endothelial cell activation. May act as a nuclear transcription factor that negatively regulates the expression of cardiac genes. Induction seems to be correlated with apoptotic cell death in hepatoma cells. |
Cellular Location | Nucleus |
Tissue Location | Mainly expressed in activated vascular endothelial cells. To a lower extent, also expressed in hepatoma cells |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
May play an important role in endothelial cell activation. May act as a nuclear transcription factor that negatively regulates the expression of cardiac genes. Induction seems to be correlated with apoptotic cell death in hepatoma cells.
References
Chu W.,et al.J. Biol. Chem. 270:10236-10245(1995).
Park J.-H.,et al.Cancer Res. 65:2804-2814(2005).
Deloukas P.,et al.Nature 429:375-381(2004).
Miller M.K.,et al.J. Mol. Biol. 333:951-964(2003).
Cinquetti R.,et al.Hum. Mutat. 29:468-474(2008).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.